chr2-154855623-A-AT
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BA1
The NM_002239.4(KCNJ3):c.*310_*311insT variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.22 ( 3904 hom., cov: 19)
Exomes 𝑓: 0.15 ( 251 hom. )
Consequence
KCNJ3
NM_002239.4 3_prime_UTR
NM_002239.4 3_prime_UTR
Scores
Not classified
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 2.87
Genes affected
KCNJ3 (HGNC:6264): (potassium inwardly rectifying channel subfamily J member 3) Potassium channels are present in most mammalian cells, where they participate in a wide range of physiologic responses. The protein encoded by this gene is an integral membrane protein and inward-rectifier type potassium channel. The encoded protein, which has a greater tendency to allow potassium to flow into a cell rather than out of a cell, is controlled by G-proteins and plays an important role in regulating heartbeat. It associates with three other G-protein-activated potassium channels to form a heteromultimeric pore-forming complex that also couples to neurotransmitter receptors in the brain and whereby channel activation can inhibit action potential firing by hyperpolarizing the plasma membrane. These multimeric G-protein-gated inwardly-rectifying potassium (GIRK) channels may play a role in the pathophysiology of epilepsy, addiction, Down's syndrome, ataxia, and Parkinson's disease. Alternative splicing results in multiple transcript variants encoding distinct proteins. [provided by RefSeq, May 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.343 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNJ3 | NM_002239.4 | c.*310_*311insT | 3_prime_UTR_variant | 3/3 | ENST00000295101.3 | NP_002230.1 | ||
KCNJ3 | NM_001260508.2 | c.*891_*892insT | 3_prime_UTR_variant | 2/2 | NP_001247437.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KCNJ3 | ENST00000295101.3 | c.*310_*311insT | 3_prime_UTR_variant | 3/3 | 1 | NM_002239.4 | ENSP00000295101.2 | |||
KCNJ3 | ENST00000544049.2 | c.*891_*892insT | 3_prime_UTR_variant | 2/2 | 1 | ENSP00000438410.1 | ||||
KCNJ3 | ENST00000651198.1 | c.*310_*311insT | 3_prime_UTR_variant | 4/4 | ENSP00000498639.1 |
Frequencies
GnomAD3 genomes AF: 0.223 AC: 33560AN: 150266Hom.: 3898 Cov.: 19
GnomAD3 genomes
AF:
AC:
33560
AN:
150266
Hom.:
Cov.:
19
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.153 AC: 2452AN: 15980Hom.: 251 Cov.: 0 AF XY: 0.152 AC XY: 1275AN XY: 8386
GnomAD4 exome
AF:
AC:
2452
AN:
15980
Hom.:
Cov.:
0
AF XY:
AC XY:
1275
AN XY:
8386
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.223 AC: 33582AN: 150356Hom.: 3904 Cov.: 19 AF XY: 0.227 AC XY: 16683AN XY: 73414
GnomAD4 genome
AF:
AC:
33582
AN:
150356
Hom.:
Cov.:
19
AF XY:
AC XY:
16683
AN XY:
73414
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at